Saturday 20 February 2016

Valganciclovir and bevacizumab for recurrent glioblastoma: A single-institution experience

http://www.ncbi.nlm.nih.gov/pubmed/26893852

I will upload this to the Library.  Keep in mind this was only 13 patients.
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)